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Abstract
Background: The resilience and Quality of Life (QOL) of adolescent cancer survivors was compared with those of
children with other diseases to identify the patterns and factors that affect resilience and QOL The purpose of the
present study was to compare the resilience and QOL between adolescent blood cancer survivors and adolescents
with Congenital Heart Disease (CHD).
Methods: A cross-sectional study was conducted in two hospitals. Ninety-four adolescent blood cancer survivors
and 81 adolescents with CHD completed a self-reported questionnaire regarding resilience, QOL, and general
characteristics. Independent t-test and ANCOVA were used to compare the resilience and QOL between adolescent
blood cancer survivors and adolescents with CHD.
Results: The resilience of adolescent blood cancer survivors was significantly lower than that of adolescents with
CHD, and the QOL of adolescent blood cancer survivors was not different from that of adolescents with CHD.
Conclusions: The experiences of adolescent blood cancer survivors were different from those of adolescents with
CHD even though they are of the same ages. Adolescents with chronic disease have a different level of illness
controllability and self-regulation according to their disease and situation. Therefore, health-providers need to
develop the specific programs for improving resilience and QOL of adolescents with chronic illness with focusing
their characteristics and situations.
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Background
Blood cancer is the most common cancer type among
children and adolescents aged 0–14 years in the United
State and Korea [1, 2]. Blood cancer is the second most
common cause of death for children aged 0–14 years
among various types of cancers in the United State and
Korea [1, 3]. However, due to advanced treatment, the
five-year survival rate of blood cancer among children
aged 0–14 years is 85% in the United State as well as in
Korea [1, 2]. Therefore, paediatric blood cancer was re-
cently recognized as a chronic illness.
The majority of paediatric blood cancer survivors live
to be adults, but they experience anxiety about recur-
rence and experience a high burden of late effects [4].
They also need to accomplish tasks according to devel-
opmental stage, which could cause psychological health
problems. Because paediatric cancer survivors tend to
have overall psychological difficulties compared to the
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general population [5], health providers should consider
psychosocial functioning for these patients.
Quality of Life (QOL) may be considered to be one of
the indicators of psychosocial outcome and resilience
may influence paediatric cancer survivors’ QOL [6].
Many researchers used QOL and resilience as variables
to investigate psychosocial functioning of adolescents
with chronic illness [4, 5, 7, 8]. Resilience refers to the
process of effectively negotiating, adapting to, or man-
aging a significant source of stress or trauma [9]. Assets
and resources within an individual and her/his life and
environment facilitate the capacity for adaptation and
‘bouncing back’ in the face of adversity [9]. The adoles-
cent resilience model (ARM) is designed to describe the
processes and outcomes of resilience experienced by ad-
olescents with cancer and other chronic illness [10]. The
ARM consists of 3 classes of protective factors (individ-
ual, family, and social) and 2 classes of risk factors (indi-
vidual and illness-related) [10]. These protective and risk
factors affect the adolescent’s outcome of resilience and
QOL [11]. Resilience plays a positive role as protective
factors in response to stress and QOL refers to a global
sense of well-being in the context of the ARM [11]. The
resilience and QOL of patients with chronic disease can
vary according to the disease, because patient adversity
and process of adaptation to a chronic disease are het-
erogeneous [12]. For example, Limber et al. [13] ex-
plained that paediatric liver transplantation recipients
reported lower QOL than children with type 1 diabetes.
Accordingly, the resilience and QOL of paediatric cancer
survivors in comparison to those of children with other
diseases need to be determined in order to identify the
patterns and factors that affect resilience and QOL.
Many researchers have studied the psychosocial issues
of people with chronic illness. The researchers reported
that the people who have strong internal health locus of
control (the belief that they can control their health con-
dition) was likely to learn self-management [14] and
showed high QOL [15], self-esteem, and life satisfaction
[16]. The people having cancer showed lower scores of
internal health locus of control than those of healthy
people [17] because they continuously experienced a fear
of recurrence [18]. However the sure way to prevent
cancer recurrence is not yet known. On the other hand,
the scores of internal health locus of control in people
with heart disease were higher than those in healthy
people at comparing the two studies using the same
scale for investigating internal health locus of control
[17, 19]. These mean that psychological problems can be
different in the people with cancer and heart disease,
even though both diseases were considered as chronic
disease. In addition, the leading causes of death for teen-
ager population were accident, homicide, suicide, cancer
and heart disease from 1999 to 2006 [20]. And the
leading causes of death among patients aged one to 19
years were heart disease and cancer in 2014 [3]. There-
fore, it is valuable to compare the resilience and QOL of
adolescents blood cancer survivors, the resilience and
QOL of adolescents with Congenital Heart Disease (CHD)
was investigated. The purpose of the present study was to
compare the resilience and QOL between adolescent can-
cer survivors and adolescents with CHD because there
have not been sufficient comparative studies to date. Sci-
entific investigation about the different points from the
present study can be a cornerstone to develop the specific
program for improving psychosocial functioning of ado-
lescent cancer survivors. It was hypothesized that adoles-
cent cancer survivors would show low levels of QOL and
resilience compared to adolescents with CHD.
Methods
Study design
The cross-sectional study was conducted to investigate
and compare resilience and QOL between adolescent
blood cancer survivors and adolescents with CHD.
Setting and participants
Researchers obtained the approvals of two university-
affiliated tertiary hospitals which are located in the same
city to secure a number of subjects. Each hospital has ex-
pertise in paediatric leukemia and CHD. To recruit ado-
lescents blood cancer survivors, a research assistant visited
an out-patient paediatric cancer clinic at a university-
affiliated hospital, and a nurse practitioner recommended
patients 12 to 20 years old, diagnosed with adolescents
blood cancer, and under maintenance therapy or follow
up after finishing treatment. Adolescent who can lead a
daily life were included and adolescents currently suffering
from complications were exluded. To recruit adolescents
with CHD, a research assistant visited an out-patient
paediatric cardiology clinic at another university-affiliated
hospital, and a nurse practitioner recommended patients
12 to 20 years in age and diagnosed with CHD. Partici-
pants were recruited during summer break, from July to
August, 2017, to maximize the amount of data. Initially,
106 adolescent cancer survivors and 81 adolescents with
CHD took part in this study, but 12 adolescent cancer sur-
vivors failed to complete the questionnaire. In the end, 94
adolescent blood cancer survivors and 81 adolescents with
CHD participated in this study. At a minimum sample size
of 64 per group with a t-test for two groups, effect size
was 0.5, and power was 0.80 from G*power 3.0.10 [21].
Data collection
This study was approved by the Institute Review of
Board of the two involved hospitals before data collec-
tion. Informed consent was obtained from participants
over 18 years in age and from both participants and
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parents from patients under 18 years of age. Research as-
sistants explained the aims and necessity of this study to
the participants and parents, and the recruited adoles-
cents who decided to take part in this study completed
the questionnaire in the waiting room.
Measurements
Resilience
The resilience scale developed by Wagnild and Young
[22] was used to evaluate and compare the resilience be-
tween adolescent blood cancer survivors and adolescents
with CHD. The Resilience Scale consists of two sub-
scales: personal competence and acceptance of self and
life. The possible range was from 25 to 175, and a higher
score indicates higher resilience. Wagnild [23] reported
that a score over 145 means high resilience and a score
under 125 means low resilience. This self-reported in-
strument consisted of 25 items rated on a 7-point Likert
scale. The resilience scale Korean version, which was
verified by Lee, Lee, and Choi (2017) was used in this
study. The Cronbach’s alpha in the original study was
.92, and that in this study was .94.
QOL
The KIDSCREEN 52 health questionnaire for children
and young people developed by the KIDSCREEN group
was used to evaluate and compare the QOL between
adolescent blood cancer survivors and adolescents with
CHD [24]. This instrument consisted of 52 items and 10
subscales of physical activities and health (5 items), feel-
ings (6 items), general mood (7 items), self-perception (5
items), free time (5 items), family and home life (6
items), money matters (3 items), friends (6 items), school
and learning (6 items), and bullying (3 items). KIDS
CREEN 52 is performed using a 5-point Likert self-
report scale. A higher score indicates higher QOL. The
KIDSCREEN Korean version, which was verified by
Hong [25], was used to test the Korean adolescents with
chronic illness. The Cronbach’s alphas in the previous
study ranged from .77 to .95 for verifying the reliability
of the KIDSCREEN Korean version [25], and the Cron-
bach’s alphas in this study were from .75 to .95.
General characteristics
General characteristics were collected by self-report
questionnaire that consisted of gender, age, school level,
religion, parent marital status and education level, and
perceived economic status. Clinical diagnosis was
assessed through the medical record. The diagnosis for
adolescents blood cancer was classified as acute lympho-
blastic leukemia, acute myeloid leukemia, lymphoma,
and myeloma. The diagnosis for CHD was classified as
simple, moderate severity, and great complexity, which
was the classification of the Task Force 1 of the 32nd
Bethesda Conference of the American College of Cardi-
ology [26].
Data analysis
SPSS 20.0 was used to analyze the data. The descriptive
analysis was conducted to evaluate the homogeneity of
two groups: adolescent blood cancer survivors and adoles-
cents with CHD. T-test was used to compare the resili-
ence and QOL between adolescent blood cancer survivors
and adolescents with CHD. ANCOVA was conducted to
evaluate the resilience and QOL according to group (ado-
lescent blood cancer survivors vs. adolescents with CHD)
and school level. The absolute values of skewness and ex-
cess kurtosis were calculated to be lower than one, which
were in acceptable ranges for assuming a normal distribu-
tion [27]. School level was included as an independent
variable because it was significantly different between the
groups in the previous analysis.
Results
Diagnoses of the two groups
As shown in Table 1, Fifty-eight (53.2%), fourteen (14.9%),
and twenty-two (23.4%) participants in the group of ado-
lescent blood cancer survivors had been diagnosed
leukemia, lymphoma, and myeloma, respectively. Fifteen
(18.5%), thirty-three (40.7%), and thirty-three (40.7%) ado-
lescents with CHD had been diagnosed with ‘simple’,
‘moderate severity’ and ‘great complexity’, respectively.
Homogeneity of the two groups
s shown in Table 2, general characteristics were not sig-
nificantly different between adolescent blood cancer sur-
vivors and adolescents with CHD, with the exception of
school level (p = .02). Seventy-five adolescent blood can-
cer survivors (79.8%) attended middle or high school,
and 11 participants (11.7%) attended college, while 52
adolescents with CHD (64.2%) attended middle or high
school, and 24 participants (29.6%) attended college.
Sixty-two (66.0%) and 49 (60.5%) adolescent blood can-
cer survivors and adolescents with CHD, respectively,
were male. Forty-two (45.2%) and 34 (42%) adolescent
blood cancer survivors and adolescents with CHD, re-
spectively, were religious. Eighty-two adolescent blood
cancer survivors (89.1%) perceived their economic status
Table 1 Diagnoses of the participants
Adolescent blood cancer survivors Adolescents with CHD
Diagnosis n (%) Diagnosis n (%)
Acute lymphoblastic leukemia 50 (53.2) Simple 15 (18.5)
Acute myeloid leukemia 8 (8.5) Moderate severity 33 (40.7)
Lymphoma 14 (14.9) Great complexity 33 (40.7)
Myeloma 22 (23.4)
Total 94 81
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as above average, whereas 71 adolescents with CHD
(87.6%) perceived their economic status as above
average.
Comparison of resilience and QOL between adolescent
blood cancer survivors and adolescents with CHD
The resilience of adolescent blood cancer survivors was
significantly lower than that of adolescents with CHD
(p = .03). The resilience mean scores were 121.83 and
129.27 in adolescent blood cancer survivors and adoles-
cents with CHD, respectively. The resilience mean score
of adolescent blood cancer survivors was low according
to the criteria by Wagnild.16 With regard to QOL, the
mean score of adolescent blood cancer survivors was
202.99, and that of adolescents with CHD was 202.14;
therefore, there was not a significant difference between
groups (p = .75) (Table 3).
Resilience and QOL according to group and school level
Table 4 and Fig. 1 showed the results of ANCOVA. Be-
cause school level was significantly different in the previ-
ous analysis for the homogeneity of the two groups, we
assigned group and school level as independent vari-
ables. The resilience of adolescent blood cancer survi-
vors was significantly lower than that of adolescents
with CHD (p = .01). The resilience did not differ signifi-
cantly according to school level (p = .58); however, ado-
lescent blood cancer survivors had a significantly lower
resilience than adolescents with CHD in the participants
in the category of others, including those who had taken
a leave of absence from school or graduated. The QOL
Table 2 General characteristics of the participants and homogeneity of the two groups
Variables Adolescent blood cancer survivors Adolescents with CHD X2/t (p)
Gender Male 62 (66.0) 49 (60.5) 0.56 (.53)
Female 32 (34.0) 32 (39.5)
Age in years 16.27 ± 2.04 16.48 ± 2.33 −0.65 (.52)
School Middle 34 (36.2) 29 (35.8) 10.07 (.02)
High 41 (43.6) 23 (28.4)
College 11 (11.7) 24 (29.6)
Others 8 (8.5) 5 (6.2)
Siblings No 16 (17.0) 15 (18.5) 0.07 (.48)
Yes 78 (83.0) 66 (81.5)
Religion No 51 (54.8) 47 (58) 0.18 (.76)
Yes 42 (45.2) 34 (42)
Parental marital status Married 83 (88.3) 72 (88.9) 0.02 (.55)
Divorce or bereaved 11 (11.7) 9 (11.1)
Father’s education level <High school 3 (3.3) 4 (5.7) 3.57 (.17)
High school 42 (45.7) 22 (31.4)
College or beyond 47 (51.1) 44 (62.9)
Mother’s education level <High school 1 (1.1) 2 (2.7) 1.03 (.59)
High school 43 (46.7) 30 (41.1)
College or beyond 48 (52.2) 41 (56.2)
Perceived economic status Bad 10 (10.9) 10 (12.3) 2.81(.25)
Average 61 (66.3) 44 (54.3)
Good 21 (22.8) 27 (33.3)
Others: leave of absence from school or graduated
Table 3 Comparison of resilience and QOL in adolescent blood cancer survivors and adolescents with CHD
Variable Adolescent blood cancer survivors Adolescents with CHD T (p)
Resilience 121.83 ± 27.19 129.27 ± 17.19 −2.19 (.03)
Personal Competence 84.87 ± 19.71 90.19 ± 13.14 −2.12 (.04)
Acceptance of self and life 36.96 ± 8.44 39.09 ± 5.49 −2.01 (.04)
QOL 202.99 ± 27.30 202.14 ± 25.41 0.21 (.83)
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of adolescent blood cancer survivors was not different
from that of adolescents with CHD (p = .41) (Table 4).
Discussion
Our findings indicate that the resilience of adolescent
cancer survivors was significantly lower than that of ado-
lescents with CHD. Adolescents blood cancer and CHD
were perceived as chronic illnesses, indicating that ado-
lescent blood cancer survivors and adolescents with
CHD live with uncertainty [28], similar to other adoles-
cents with chronic illness [29]. adolescents with CHD
experienced uncertainty due to repeated treatment and
complications [30], while adolescent cancer survivors ex-
perienced uncertainty due to the possibility of relapse
and the side effects of treatment [31]. The repeated
treatment for adolescents with CHD was planned out as
far as possible, and the education program focused on
giving adolescents with CHD information for how to
prevent complications [32]. However, the relapse possi-
bility cannot be determined by education; therefore, ado-
lescent blood cancer survivors might experience more
uncertainty than adolescents with CHD. It is difficult for
adolescent blood cancer survivors to perceive illness
controllability and self-regulation, because there are no
known methods to prevent second cancer or relapse.
The parallel model which was developed by Leventhal
stated that health threats generate both fear control and
danger control [33]. Fear control and danger control re-
ferred to the parallel actions that are undertaken for
their efficacy in reducing the negative emotions and the
threat themselves [33]. The information about health
threats lead to the perception of fear and danger, then,
action plans are undertaken to reduce them [33]. The
parallel process model proposed that cognition of health
threats was a necessary condition for danger control
[33]. However, adolescent blood cancer survivors who
recognized their health threat could not control the dan-
ger of second cancer or relapse. Illness controllability
was associated with good psychological and physical ad-
justment [29]. Self-regulation involves adherence to daily
tasks such as nutrition and prevention of infection and
improvement of health outcomes [12]. However, adoles-
cent blood cancer survivors had difficulties perceiving
illness controllability and self-regulation. High illness
controllability and self-regulation were associated with
high resilience and high frequency of problem solving
[34]. The adolescent blood cancer survivors in this study
seemed to show lower resilience than adolescents with
CHD because they had difficulty achieving illness con-
trollability and self-regulation.
Table 4 The factors for resilience and QOL analyzed by
ANCOVA
Dependent Variable Independent variables df F p
Resilience Model 7 1.61 .14
Group by diagnosis 1 7.27 .01
School 3 0.44 .58
Group x School 3 1.51 .22
QOL Model 7 1.12 .35
Group by diagnosis 1 0.67 .41
School 3 2.35 .07
Group x School 3 0.58 .63
Fig. 1 Resilience according to group and school level. a leave of absence from school or graduated
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In addition, adolescent blood cancer survivors endure
longer duration of treatment compared to adolescents
with CHD. For example, children and adolescents with
acute lymphoblastic leukemia receive several months or
years of treatment [35]. Many blood cancer survivors ex-
perience difficulties at school [12] and grade retention
[36] due to the long treatment period, requiring absence
from school. Peer relationships and participation at school
facilitate disease adaptation and improvement of resilience
[37]. Our finding also showed a large difference in resili-
ence between adolescent blood cancer survivors and ado-
lescents with CHD for participants who had required a
leave of absence from school or graduated. Difficult situa-
tions such as longer duration of treatment and grade re-
tention could be associated with lower resilience of
adolescent cancer survivors in comparison to adolescents
with CHD. The psychological factors associated with re-
silience were positive emotion, acceptance, spirituality, so-
cial support, and active coping style [38]. Therefore,
health-providers need to develop a resilience improve-
ment program focused on positive emotion, acceptance,
and social support in addition to active coping styles such
as education for adolescents blood cancer survivors.
The QOL of adolescent cancer survivors was not sig-
nificantly different from that of adolescents with CHD.
A systematic review study reported that the studies
about the QOL of adolescents with chronic disease were
heterogeneous; the majority of the studies reported a
significantly higher risk of impairment on QOL, whereas
other studies reported a significantly lower risk of im-
pairment on QOL in adolescents with chronic disease
[39]. Hamner et al. [40] used hierarchical regression ana-
lysis in their study of adolescents cancer patients and
demonstrated that QOL was more highly associated with
parental chronic stress than with time since diagnosis.
Therefore, the QOL of adolescents with chronic disease
could be more highly affected by individual psycho-
logical factors, protective factors, and the adaptation
process than with the medical diagnosis. Future research
is needed to investigate the variables related to QOL of
adolescents blood cancer survivors.
Our study has several limitations. Firstly, resilience
and QOL which are the dependent variables in the
present study were influenced by others factors such as
severity of illness and comorbidity. However, adolescent
who can lead a daily life were included and adolescent
who were currently suffering from complications were
excluded in this study. And adolescent cancer survivors
and adolescents with CHD were recruited from different
hospitals in the same city. Therefore, further research
need to be carried out in view of these exogenous vari-
ables. Secondly, the present study was a cross-sectional
study and the time after diagnosis and the time after
treatment were not included as variables. The time after
diagnosis and the time after treatment can be important
variables which influence on resilience and QOL. Further
longitudinal studies considering time after diagnosis and
treatment are needed. Thirdly, the mean age of this study
sample was 16 years and the subjects were an older paedi-
atric group. Future research for exploring resilience and
QOL of younger age groups and for investigating the ef-
fect of age on resilience and QOL are needed.
Conclusion
This study showed that the resilience of adolescent cancer sur-
vivors was significantly lower than that of adolescents with
CHD. Adolescent cancer survivors experienced uncertainty
due to relapse possibility and side effects of treatment; how-
ever, relapse possibility cannot be determined by education. It
is difficult for adolescent cancer survivors to perceive illness
controllability and self-regulation. In addition, living in a diffi-
cult situation such as longer duration of treatment or grade
retention could be factors associated with lower resilience of
adolescent cancer survivors compared to adolescents with
CHD. Due to advanced medical treatments, adolescents blood
cancer as well as CHD are regarded as chronic disease. How-
ever, the experiences of adolescent blood cancer survivors
were different from those of adolescents with CHD even
though they are of the same ages. Adolescents with chronic
disease have a different level of illness controllability and self-
regulation according to their disease and situation. Therefore,
health-providers need to develop the specific programs for im-
proving resilience and QOL of adolescents with chronic illness
with focusing their characteristics and situations.
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